Boston Scientific Corporation (BSX): Price Target and June Short Interest Disclosure

Boston Scientific Corporation (BSX) : The most positive equity analysts on Boston Scientific Corporation (BSX) expects the shares to touch $28, whereas, the least positive believes that the stock will trade at $20 in the short term. The company is covered by 19 Wall Street Brokerage Firms. The average price target for shares are $24.11 with an expected fluctuation of $2.4 from the mean.

Boston Scientific Corporation (BSX) encountered a drop of 14.6% or -3,440,750 shares in the short positions. The number dropped from 23,595,642 on June 15,2016 to 20,154,892 on June 30,2016. The final interest is 1.5% of the floated stock. The days to cover figure of 1 can be arrived using the average daily exchange of 16,128,706 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Guggenheim Securities initiates coverage on Boston Scientific Corporation (NYSE:BSX). The current rating of the shares is Buy, according to the research report released by the firm. The rating by the firm was issued on June 9, 2016.


Boston Scientific Corporation (NYSE:BSX): stock turned positive on Thursday. Though the stock opened at $23.79, the bulls momentum made the stock top out at $23.86 level for the day. The stock recorded a low of $23.66 and closed the trading day at $23.78, in the green by 0.63%. The total traded volume for the day was 7,583,495. The stock had closed at $23.63 in the previous days trading.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.